Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / ALXN - Alexion Delivers With Achillion Acquisition; Good Deal To Protect Its Mainstay Drug


ALXN - Alexion Delivers With Achillion Acquisition; Good Deal To Protect Its Mainstay Drug

Alexion Pharmaceuticals (ALXN) announced that it would acquire Achillion Pharmaceuticals (ACHN) for approximately $930 million. There are other stipulations that were added to make this deal decent for Achillion. There are still some measures that must be closed before such a deal can be completed. This acquisition was a smart one for Alexion, because it will add another drug that treats complement mediated diseases. I believe this was a move that Alexion had to make, otherwise it could have faced competition from Achillion in the coming years. Sales of Alexion Pharmaceuticals'

Read more ...

Stock Information

Company Name: Alexion Pharmaceuticals Inc.
Stock Symbol: ALXN
Market: NASDAQ
Website: alexion.com

Menu

ALXN ALXN Quote ALXN Short ALXN News ALXN Articles ALXN Message Board
Get ALXN Alerts

News, Short Squeeze, Breakout and More Instantly...